Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 620 results for "kexin"

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibito...

Summary 'Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the ... Individual.com, 1 month ago
FDA gives PCSK9 inhibitor priority review Cardiovascular Business, 5 days ago

2 images for "kexin"

Pharmaceutical Business Review, 4 days ago
Channel NewsAsia, 2 weeks ago
Miami Herald

Krueger wins men's 1,000 at Ohno Invitational

John-Henry Krueger won the men's 1,000-meter race and China's Fan Kexin dominated the women's competition at the Apolo Ohno Invitational on Friday night. Krueger was the only American to win an event, beating Canada's Charles Hamelin and China's ...
 Miami Herald2 months ago
[x]  

Fan Kexin wins women's 500m at ISU Short Track World Cup

It was the final day of competition from the latest stop on the Short Track Speed Skating circuit. And China was looking to add to their medal haul from the opening day, when they grabbed two gold medals in Seoul. In the women's 3000m relay, team ...
 CNTV1 month ago Fan spearheads China in short track World Cup  China.org.cn1 month ago XINHUA - Fan spearheads China in short track World Cup  Namibia Press Agency1 month ago

Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels

Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.1 "The long-term ...
 Individual.com2 months ago Amgen reports encouraging data from Phase II and III high cholesterol analyses  Individual.com2 months ago Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab  4 Traders2 months ago AMGEN PRESENTS LONG-TERM DATA OF INVESTIGATIONAL CHOLESTEROL-LOWERING MEDICATION EVOLOCUMAB ACROSS LIPID AND LDL-C LEVELS  Noodls2 months ago
[x]  
PHP Developer's Journal

Research and Markets: China Paraquat Export Overview Report 2014-2015

Research and Markets ( http://www.researchandmarkets.com/research/swbspq/china_paraquat ) has announced the addition of the "China Paraquat Export Overview" report to their offering. China paraquat product export overlook provides ...
 Town Hall1 day ago China Paraquat Export Overview Report 2014-2015  Individual.com21 hours ago Global Slitter Industry and PIN Diode Market 2014 Research Reports  Stock Nod1 month ago Global PIN Diode Industry Report 2014-2020  Individual.com1 month ago
[x]  
Pharmaceutical Business Review

Sanofi and Regeneron Announce Praluent (alirocumab) BLA Accepted for Priority Review by FDA

Treatment for High Cholesterol Paris and Tarrytown, New York January 26, 2015 Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License ...
 Drugs.com22 hours ago Hypercholesterolemia Treatment Granted FDA Priority Review  Pharmacy Times4 days ago Sanofi and Regeneron's Praluent BLA gains priority review from US FDA26-01-2015  Pharma Letter4 days ago Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Trials Evaluating Monthly Alirocumab  Drugs.com4 days ago
[x]  

Regeneron Pharmaceuticals : Details Findings in Immunoglobulins (Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in...

Regeneron Pharmaceuticals Inc. Details Findings in Immunoglobulins (Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial) By a ...
 4 Traders1 week ago

The year in cardiology 2014: prevention

Preamble This overview of key studies, published in 2014, regarding epidemiology and prevention of cardiovascular disease (CVD) illustrates the great potential of CVD prevention as summarized in recent guidelines. New insights became available in ...
 ​European Heart Journal1 week ago

AHA Puts on a Big Show in the City of Big Shoulders

The American Heart Association's annual scientific session in Chicago offered insights on the latest therapies and practices, from statin treatments and screening tools to readmissions and communications. Here is a roundup of presentations from the ...
 Cardiovascular Business1 week ago

CCF Chronicles: Breakthrough Heart Tx Coming in 2015?

In this inaugural installment of guest posts from clinicians at the Cleveland Clinic, Steven E. Nissen, MD , explains why he sees 2015 as a momentous year for cardiology. During the last decade, pharmaceutical companies have introduced very few ...
 MedPage Today2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less